Semafore Pharmaceuticals

About:

Semafore Pharmaceuticals discovers and develops clinical-stage drugs.

Website: http://www.semaforepharma.com

Top Investors: Twilight Venture Partners

Description:

Semafore Pharmaceuticals is a development-stage drug discovery company that targets the PI3K cell signaling pathways to create anti-cancer drugs. Their PI3K inhibitors are used to treat tumors and have the potential to treat cancers of the brain, lungs, and hemological systems.

Total Funding Amount:

$13.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Indianapolis, Indiana, United States

Founded Date:

2000-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2007-01-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai